Growth PotentialPotential for strong specialty pharmacy growth and a return to historic Medicare Advantage trend levels could drive mid-teens adjusted EPS growth.
ProfitabilityCVS is well positioned to execute on improved profitability through significant contributions from Medicare Advantage Star ratings bonus payments, operational cost savings, and strategic changes in coverage.
ValuationAnalyst reiterates a Buy rating as CVS shares trade at a low valuation, offering potential upside despite risks.